Quan Yao Ho

ORCID: 0000-0002-0884-7076
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Transplantation Outcomes and Treatments
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Impact on Reproduction
  • Long-Term Effects of COVID-19
  • Organ Donation and Transplantation
  • COVID-19 and healthcare impacts
  • Organ Transplantation Techniques and Outcomes
  • Cytomegalovirus and herpesvirus research
  • Renal and Vascular Pathologies
  • Mosquito-borne diseases and control
  • Renal Diseases and Glomerulopathies
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Neurological Complications and Syndromes
  • Pharmacological Effects and Toxicity Studies
  • Transplantation: Methods and Outcomes
  • Immunodeficiency and Autoimmune Disorders
  • CNS Lymphoma Diagnosis and Treatment
  • Malaria Research and Control
  • Virus-based gene therapy research
  • Animal Virus Infections Studies
  • Pregnancy and Medication Impact
  • Cardiac Valve Diseases and Treatments
  • Lymphoma Diagnosis and Treatment
  • Amyloidosis: Diagnosis, Treatment, Outcomes

SingHealth Duke-NUS Academic Medical Centre
2020-2025

Singapore General Hospital
2019-2025

University of Oxford
2023-2025

Oxford Research Group
2024

Boston University
2023-2024

SingHealth
2020-2023

Duke-NUS Medical School
2020-2023

National University of Singapore
2010-2022

Cherie Le Si Gan, Shimin Jasmine Chung, Quan Yao Ho, Thuan Tong Tan, Ban Hock Ian Tatt Liew, Carolyn Shan-Yeu Tien, Sobhana Thangaraju, Terence Kee. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.24.0045

10.4285/ctr.24.0045 article EN cc-by-nc Deleted Journal 2025-02-06

Background. Kidney biopsy is important to guide the management of allograft dysfunction but has a risk complications. This review aimed determine incidence and factors complications after kidney biopsy. Methods. systematic meta-analysis randomized controlled trials, cohort studies, or case-control studies indexed on PubMed, Embase, Cochrane Central Register Controlled Trials, World Health Organization International Clinical Trials Registry, ClinicalTrials.gov, limited English language, from...

10.1097/tp.0000000000004033 article EN Transplantation 2022-01-10

Neurolymphomatosis is a lymphoid malignancy of the peripheral nervous system and its natural history poorly understood.

10.1038/s44276-024-00053-x article EN cc-by BJC Reports 2024-04-23

Dengue virus (DENV), a mosquito-borne pathogen, causes systemic infections. There are no clear guidelines regarding the screening of donor blood is used in endemic countries to prevent transfusion or transplant-associated dengue. DENV has been shown be detected urine samples even when viremia undetectable. We describe an incident dengue where tested negative for but positive viuria resulting transmission our two kidney recipients. Both recipients resolved infection uneventfully, with adverse...

10.1111/ajt.16540 article EN cc-by-nc-nd American Journal of Transplantation 2021-02-14

Introduction: Coronavirus Disease 2019 (COVID-19) has significantly affected the way healthcare is delivered in Singapore. Healthcare services such as renal transplantation had to rapidly adjust and meet needs (1) protect patients staff, (2) ramp up, conserve or redeploy resources while (3) ensuring that critical remained operational. This paper aims describe experience of transplant programme at Singapore General Hospital (SGH) responding risks constraints posed by pandemic. Methods...

10.47102/annals-acadmedsg.2020316 article EN Annals of the Academy of Medicine Singapore 2020-09-30

The coronavirus disease 2019 (COVID-19) pandemic has caused significant psychological distress globally. Our study assessed the prevalence of and associated factors during COVID-19 among kidney transplant recipients donors.

10.1186/s12882-022-02698-7 article EN cc-by BMC Nephrology 2022-02-24

Double-filtration plasmapheresis (DFPP) has been utilized for immunomodulation in kidney transplantation. Anticoagulation is important to maintain circuit patency during DFPP. We aimed compare the efficacy and safety of regional citrate anticoagulation (RCA) with systemic heparin DFPP transplant recipients.A retrospective cohort study was conducted RCA (RCA-DFPP) (Hep-DFPP) among recipients a single tertiary center.A total 112 sessions were performed 23 subjects, which 62 RCA-DFPP 50...

10.1002/jca.22019 article EN Journal of Clinical Apheresis 2022-10-05

The COVID-19 pandemic is protracted and episodic surges from viral variants continue to place significant strain on healthcare systems. vaccines, antiviral therapy monoclonal antibodies have significantly reduced associated morbidity mortality. Concurrently, telemedicine has gained acceptance as a model of care tool for remote monitoring. These advances allow us safely transit our inpatient-based infected kidney transplant recipients (KTRs) hospital-at-home (HaH) care.KTRs with PCR-proven...

10.1111/nep.14155 article EN Nephrology 2023-03-06

Introduction: Percutaneous renal biopsy remains critical for the workup of allograft dysfunction but is associated with risk bleeding. Prophylactic intravenous desmopressin has been proposed to reduce bleeding in native biopsies, its efficacy transplant population unclear and adverse events such as severe hyponatraemia have reported. Materials Methods: We conducted a single-centre retrospective cohort study involving adult (≥21 years old) recipients impaired function (serum creatinine ≥150...

10.47102/annals-acadmedsg.2019164 article EN Annals of the Academy of Medicine Singapore 2020-02-29

Abstract Aim Compared to Standard Criteria Donors (SCD), Expanded Donor (ECD) kidneys are associated with poorer outcomes, although pre‐transplant biopsy may mitigate risks. This study assessed 5‐year outcomes of deceased‐donor kidney transplant recipients, comparing recipients ECD allografts evaluated histologically SCD and clinically. Methods is a single‐centre retrospective study. From November 2005 December 2009 (Era 1), donors were clinically for suitability donation. October 2017 2),...

10.1111/nep.13788 article EN Nephrology 2020-09-28

Adenovirus is an important cause of haemorrhagic cystitis in kidney transplant recipients. The optimal treatment for adenovirus-associated (AAHC) unknown. Intravenous cidofovir may be effective, but nephrotoxicity a major concern. use intravesical viral has been reported haematopoietic stem cell recipients and associated with lower risk nephrotoxicity, its not We report the AAHC recipients, along review literature.

10.1093/ckj/sfz016 article EN cc-by-nc Clinical Kidney Journal 2019-01-16

We present a case of asymptomatic coronavirus disease 2019 (COVID-19) diagnosed in hemodialysis patient during deceased donor renal transplantation (DDRT) evaluation and discuss the challenges excluding COVID-19 before transplantation. A 50-year-old woman with end-stage secondary to IgA nephropathy on was called up as first waitlist. She screened for based our previously published protocol1 addition chest computed tomography (CT) scan. Our her brother, only household contact, were...

10.1097/txd.0000000000001010 article EN cc-by-nc-nd Transplantation Direct 2020-05-22

Background: Calcineurin inhibitors are the cornerstone of maintenance immunosuppression after kidney transplant. While studies on predominantly Caucasian populations recommend tacrolimus over cyclosporine, effects Singapore’s local population remain unclear. Objectives: This study aimed to compare impact against cyclosporine post-transplant outcomes in our transplant population. Methods: A single-centre retrospective chart review was conducted ABO- and human leucocyte antigen...

10.1177/2010105820957370 article EN cc-by-nc Proceedings of Singapore Healthcare 2020-09-11

Cardiac evaluation before deceased donor kidney transplant (DDKT) remains a matter of debate. Data on Asian countries and with prolonged waiting times are lacking. This study aimed to assess the outcomes patients referred for DDKT after cardiac at an tertiary center.This single-center retrospective review analyzed who were waitlist placement underwent stress testing between January 2009 December 2015. Patients symptoms excluded. The primary outcome was three-point major adverse...

10.4285/kjt.22.0029 article EN cc-by-nc Korean Journal of Transplantation 2022-09-29

10.1097/tp.0000000000004972 article EN Transplantation 2024-03-23

Abstract Background and Aims Valvular heart disease (VHD) is a risk factor for adverse outcomes in end-stage kidney (ESKD) patients. However, the impact of individual valvular lesions on patients transplant waitlist unclear. This study aims to analyse relationship between different VHD all-cause mortality, determine characteristics stratified by types VHD. Method was single-center retrospective cohort ESKD who were referred placement from May 2008 February 2021 had undergone baseline...

10.1093/ndt/gfae069.1672 article EN other-oa Nephrology Dialysis Transplantation 2024-05-01
Coming Soon ...